D-Cycloserine-Lurasidone Combo Fast Tracked for cUTI, Pyelonephritis
The FDA has granted QIDP and Fast Track designations to NRX-101 for the treatment of complicated urinary tract infection and pyelonephritis.
Stay updated with breaking news from Mueller Hinton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted QIDP and Fast Track designations to NRX-101 for the treatment of complicated urinary tract infection and pyelonephritis.
The FDA has granted QIDP and Fast Track designations to NRX-101 for the treatment of complicated urinary tract infection and pyelonephritis.
The quantity of common preservatives used in cosmetics should not be determined solely based on toxicity levels, but also the inhibitory effect they may have on microorganisms that are beneficial to skin health, say researchers.
ECM Mimicking Biodegradable Nanofibrous Scaffold Enriched with Curcumin/ZnO to Accelerate Diabetic Wound Healing via Multifunctional Bioactivity
Evidence of Sharing of Carbapenem-Resistant Klebsiella pneumoniae Strains Between Intensive Care Unit Patients and the Environment